GlassScriptPhysician profile
Sarah E Rogers
NPI 1932506904
$1,513.91
in general payments reported to CMS, 2019-2025
18 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $558 · 2022: $482 · 2023: $352 · 2024: $19.46 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $412.49 | 2021-2023 | Xarelto |
| Abbott Laboratories | $168.30 | 2022-2025 | Assurity |
| Novartis Pharmaceuticals Corporation | $163.62 | 2021-2023 | |
| Esperion Therapeutics, INC. | $106.01 | 2021-2023 | Nexletol |
| Biosense Webster, INC. | $67.25 | 2023 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $65.21 | 2021 | |
| Merck Sharp & Dohme LLC | $64.29 | 2023 | Verquvo |
| Amgen INC. | $55.47 | 2021 | |
| Pfizer INC. | $55.18 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $52.99 | 2023 | Evkeeza |
| Boston Scientific Corporation | $49.08 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.11 | 2021-2024 | Lifevest |
| Chiesi USA, INC. | $42.53 | 2025 | Cleviprex |
| Abiomed | $39.52 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.91 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $34.47 | 2021 | |
| Edwards Lifesciences Corporation | $30.66 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.